Literature DB >> 6802534

The role of carbohydrate in the structure and function of nephritic factor.

D M Scott, N Amos, S R Bartolotti.   

Abstract

Six nephritic factors (NeFs) were purified from the IgG fraction of sera of patients with PLD and/or MPGN by elution from EA C43bBb. All had at least one abnormal H chain component when examined by PAGE-SDS and two additionally had a large L chain. Four different H chains were found. Their apparent molecular weights and the frequency with which they occurred were: 65,000 (one NeF), 61,500 (four NeFs), 57,000 (two NeFs) and 55,000 (one NeF) compared with 53,500 daltons for normal H chain. The molecular weight of the large L chains was 26,500 daltons (cf. 23,500 for normal L chain). Both the NeF activity and the large components were located in the F(ab')2 fragment of the molecule and after reduction the large component was found in the Fd fragment of the H chain. Neuraminidase treatment of purified NeF caused a 1-2% decrease in apparent molecular weight of the large H chain on PAGE-SDS. Mild periodate oxidation, sufficient to cause primarily loss of carbohydrate, caused a marked loss of activity. Reduction and alkylation of NeF under neutral conditions caused only a small loss of activity but after acid dissociation the H and L chains were completely inactive.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6802534      PMCID: PMC1536321     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG?

Authors:  A E Davis; M A Arnaout; C A Alper; F S Rosen
Journal:  N Engl J Med       Date:  1977-07-21       Impact factor: 91.245

3.  The cofactors required by C3 nephritic factor to generate a C3 convertase in vitro.

Authors:  N Amos; J G Sissons; J F Girard; P J Lachmann; D K Peters
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

4.  Nephritic factor: its structure and function and its relationship to initiating factor of the alternative pathway.

Authors:  R D Schreiber; O Götze; H J Müller-Eberhard
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

5.  Carbohydrate composition and complement fixation of human monoclonal IgG.

Authors:  M Tomana; W Niedermeier; F Skvaril
Journal:  Immunochemistry       Date:  1974-07

6.  The complement abnormalities of lipodystrophy.

Authors:  J G Sissons; R J West; J Fallows; D G Williams; B J Boucher; N Amos; D K Peters
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

7.  C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.

Authors:  M R Daha; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

8.  Control of the amplification convertase of complement by the plasma protein beta1H.

Authors:  J M Weiler; M R Daha; K F Austen; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

9.  Studies on the mechanism of solubilization of immune precipitates by serum.

Authors:  J Czop; V Nussenzweig
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

10.  Modulation of the alternative complement pathways by beta 1 H globulin.

Authors:  K Whaley; S Ruddy
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  4 in total

1.  Requirements for the production of high-titre C3 nephritic factor (NEF) antibody in vitro.

Authors:  M A Marín; G Fontán; M López-Trascasa
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

2.  Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus.

Authors:  M R Daha; H M Hazevoet; L A van Es
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

3.  C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.

Authors:  A T Gewurz; S M Imherr; S Strauss; H Gewurz; C Mold
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

4.  Meningococcal meningitis associated with persistent hypocomplementaemia due to circulating C3 nephritic factor.

Authors:  R A Thompson; P L Yap; R B Brettle; R E Dunmow; H Chapel
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.